Home
|
Contact Us
|
Site Map
1. HOME
1.1 News Releases
2. ABOUT MARINUS
2.1 Investors
2.2 Senior Management
2.3 Board of Directors
2.4 Advisors
2.5 Collaborators
3. GANAXOLONE
3.1 About Ganaxolone
3.2 Ganaxolone for Partial Complex Seizures
3.3 Ganaxolone for Posttraumatic Stress Disorder
3.4 Ganaxolone for Fragile-X Syndrome
3.5 References
4. TECHNOLOGY
5. CLINICAL TRIALS
5.1 Refractory Adult Partial Seizures
5.1.1 Posttraumatic Stress Disorder
5.1.2 Fragile-X Syndrome
5.2 Clinical Trials
5.3 Resources
6. NEWS & EVENTS
6.1 News Releases
6.2 Events
© Marinus Pharmaceuticals